Skip to main content
. 2019;20(9):2781–2787. doi: 10.31557/APJCP.2019.20.9.2781

Figure 4.

Figure 4

Combination Effects of miRNA-145 and Erlotinib on Lung Cancer Cell Apoptosis. Cells were transfected with miRNA-145 (50 nM) and negative control (NC) miRNA (50 nM) for 6 h. Then, erlotinib (IC50 doses of 24 and 48 h) was added to the cells. After 24 and 48 h of transfection, the apoptosis was determined using ELISA cell death assay. The data presented are mean±SD (n=3) of independent experiments; *p<0.05 compared with blank control or NC miRNA; #p<0.05 versus miRNA-145 or erlotinib